1 / 10

Section 3: CKD, CVD and mortality

Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients. Damage to the heart (Uraemic cardiomyopathy ). Damage to the arteries (Uraemic arteriopathy). Cardiovascular Mortality. Annual mortality (%). 100. Dialysis. 10. General population. 1. 0.1. Male. Female.

francie
Download Presentation

Section 3: CKD, CVD and mortality

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Section 3: CKD, CVD and mortality

  2. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy) Damage to the arteries (Uraemic arteriopathy)

  3. Cardiovascular Mortality Annual mortality (%) 100 Dialysis 10 General population 1 0.1 Male Female 0.01 Black White 25–34 35–44 45–54 55–64 65–74 75–84 85 Age (years)

  4. Synergistic effect of CKD, CHF andAnemia as risk factors for Death 2 yr mortality (n~ 200,000 5% Medicare sample) % Collins, Adv studies in Med 2003

  5. 100 10 1 Dialysis: male Dialysis: female 0.1 General population: male 0.01 General population: female 0.001 Adapted from Levey AS et al. Am J Kidney Dis 1998; 32: 853-906. DOD/0401-04 Cardiovascular Mortality Rates are Higher among Dialysis Patients

  6. CKD predicts CV events: HOPE study n=908 Events per 1000 person years n=8307 Creatinine ≥124 µmol/l Creatinine <124 µmol/l HOPE=Heart Outcomes and Prevention Evaluation study Mann et al. Ann Intern Med 2001;134:629–636

  7. Cause of death in dialysis patients

  8. CKD Outcomes:Mortality and Dialysis 27,998 CKD patients followed for 5 years Keith DS, AIM 2004;164:659-663

  9. Prevalence of Co-morbidity and Level of GFR GFR <60 ml/min GFR 60 ml/min % DM Any CVD IHD CHF Stroke/TIA PVD

More Related